Items

New study shows AI can improve thyroid cancer diagnosis with artificially created images

Researchers at Queen Mary University of London have found a new way to improve the accuracy of thyroid cancer diagnoses using artificial intelligence (AI). The study used a special type of approach, called Generative Adversarial Networks (GANs), to create realistic images of thyroid tissue samples. These fake images were then used to train AI systems to better detect cancer pathologies in real-life samples, potentially leading to more accurate diagnoses.

Date added: Tuesday, January 7, 2025

Queen Mary University of London is playing a key role in major new European research initiative to combat Multi-Drug Resistant Rheumatoid Arthritis (MDR-RA)

The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project, with a total budget of €8.4 million, is funded by the European Union under the Horizon Europe programme and the Swiss State Secretariat for Education, Research, and Innovation.

Date added: Wednesday, January 29, 2025

Professor Steffen Petersen awarded 2025 SCMR Gold Medal for excellence in cardiovascular medicine

Steffen Petersen, Professor of Cardiovascular Medicine at Queen Mary University of London, has been honoured with the Society for Cardiovascular Magnetic Resonance (SCMR) Gold Medal Award. This prestigious recognition celebrates his outstanding contributions to the field of Cardiovascular Magnetic Resonance (CMR). Professor Petersen received the award on January 31, 2025, at the SCMR annual conference held in Washington, DC.

Date added: Monday, February 3, 2025

New treatment offers quick cure for common cause of high blood pressure

A revolutionary new treatment called Targeted Thermal Therapy (Triple T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal disorder.

Date added: Monday, February 10, 2025

Almost 90% of people would agree to genetic testing to tailor medication use, survey finds

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects 85% thought that the NHS should offer pharmacogenomic testing to people with multiple health conditions 58% of people thought that the NHS should offer this testing to everyone 91% wanted access to their own pharmacogenomic data, with many wanting this via the NHS app

Date added: Thursday, February 20, 2025

Landmark study finds 69 previously unidentified genetic determinants of rare disease

The breakthrough research led by Queen Mary University of London uses a new analytical approach for identifying the genetic basis of rare diseases, which could diagnose more cases and help develop new treatments for patients.

Date added: Thursday, February 27, 2025

New adrenal stem cell marker may improve diagnosis and treatment of adrenal cancer

A large international study led by researchers at Queen Mary University of London has identified a new biomarker that could support the diagnosis and treatment of adrenal cancer.

Date added: Tuesday, March 4, 2025

From height to health: largest global genetic study reveals hidden risks and benefits linked to stature

New genetic links have been discovered between genetically-predicted height and an individual’s likelihood of developing a range of diseases and conditions. These new data could help improve early diagnosis and risk monitoring for patients.

Date added: Monday, March 3, 2025

New study of critically ill patients in Africa finds that lives could be saved with improvements to hospitals’ emergency and critical care treatments

An international study of acute hospitals across Africa found a large and neglected burden of critical illness, and a high incidence of preventable deaths due to issues with the provision of basic critical care.

Date added: Monday, March 10, 2025

Doctors warn against fluid therapy approach in surgery after global trial

A major study aiming to improve outcomes from higher risk operations has ruled out a fluid therapy approach during surgery.

Date added: Monday, January 6, 2025

Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications

A new study from Queen Mary University of London found that 9% of all adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before prescribing could therefore help avoid ADRs in these cases.

Date added: Friday, March 28, 2025

Professor Sir Mark Caulfield elected member of the Medical Research Council

Professor Caulfield, Professor of Clinical Pharmacology and Vice-Principal (Health) at Queen Mary, joins twelve other senior figures from health, science, and medicine on the Council.

Date added: Wednesday, April 2, 2025

Underfunding may contribute to higher mortality for patients in Latin America receiving surgery

An international study of the health outcomes of people receiving surgery across 17 Latin American countries found 1 in 7 developed significant complications leading to longer hospital stays and a greater risk of death.

Date added: Thursday, March 27, 2025

Queen Mary and Research Grid collaboration trials AI technology to improve efficiency in clinical trials

A project led by Queen Mary University of London, in partnership with Research Grid, Barts Health NHS Trust and the Royal Academy of Engineering, has successfully trialled a new AI-driven approach to automate clinical trial data entry, that could dramatically reduce the time and cost of running clinical trials.

Date added: Monday, May 12, 2025

Professor Morris Brown elected as Fellow of the Royal Society

Professor Morris Brown MD FRCP FMedSci FRS has been elected to the Fellowship of the Royal Society, the UK’s national academy of sciences. He is one of 90 outstanding scientists from the UK and internationally who have joined the prestigious body this year.

Date added: Tuesday, May 20, 2025

New injection could help millions with high blood pressure

Results from a clinical trial led by researchers from Queen Mary University of London, published yesterday in JAMA, show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure.

Date added: Thursday, May 29, 2025

Queen Mary University of London to lead EU-wide Resolution Biology network

Queen Mary University of London will lead a new European research initiative, following the successful award of a highly competitive grant from the European Cooperation in Science and Technology (COST) framework.

Date added: Monday, June 2, 2025

Largest twin study explores whether the environment affects people differently depending on their genes

An international team including researchers from Queen Mary have identified genetic factors that may make some individuals more or less sensitive to the environments they experience.

Date added: Tuesday, June 10, 2025

Queen Mary Emeritus Professor awarded CBE in King’s Birthday Honours

Professor Tilli Tansey recognised for her contribution to medical history and science.

Date added: Monday, June 16, 2025

2025 BSCR Autumn Meeting: Frontiers in Cardiovascular Research

The 2025 British Society for Cardiovascular Research (BSCR) Autumn Meeting, 'Frontiers in Cardiovascular Research’, will take place at William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, on the Charterhouse Square campus.

Date added: Wednesday, June 18, 2025

Barts and Queen Mary Science Festival 2025

The Barts and Queen Mary Science Festival returned to Queen Mary University of London on 24 June 2025, welcoming secondary school students aged 14 and over to the Derek Willoughby Lecture Theatre at Charterhouse Square for a day of science and medicine.

Date added: Wednesday, June 25, 2025

WHRI Annual Research Review 2025

On Wednesday 25 June we celebrated the achievements of our researchers at the WHRI Annual Research Review.

Date added: Thursday, June 26, 2025

New drug tackles uncontrolled hypertension caused by aldosterone dysregulation

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces systolic blood pressure in adults with uncontrolled hypertension (uHTN) or resistant hypertension (rHTN).

Date added: Tuesday, July 1, 2025

New understanding of how red blood cells are created could make artificial blood easier to make

Studies undertaken by researchers at Queen Mary and University of Konstanz have identified a critical chemical signal in the development of red blood cells. The discovery will help make the manufacture of artificial blood more efficient.

Date added: Friday, July 4, 2025

New drug offers hope of cure for hormone-driven high blood pressure

The commonest single cause of high blood pressure can be reversed with a new class of medicine, according to results from a clinical trial led by Queen Mary University of London.

Date added: Monday, July 14, 2025

WHRI welcomes the next generation of scientists to Charterhouse Square

From 16–17 July 2025, the William Harvey Research Institute (WHRI) at Queen Mary University of London opened its doors to 28 Year 12 and 13 students for its annual Work Experience Programme. The scheme has welcomed more than 480 aspiring scientists, doctors, and healthcare professionals since its launch in 2017.

Date added: Monday, July 21, 2025

Queen Mary researchers recognised at European Society of Cardiology Congress 2025

Researchers from Queen Mary University of London’s Centre for Advanced Cardiovascular Imaging, part of the William Harvey Research Institute, were recognised in the prestigious international Young Investigator Awards at this year’s European Society of Cardiology (ESC) Congress in Madrid (29 August – 1 September).

Date added: Monday, September 1, 2025

Living in the most polluted areas increases risk of heart failure by a quarter

People living in the UK’s most polluted neighbourhoods could be 27% more likely to develop heart failure, according to new research led by Queen Mary University of London.

Date added: Tuesday, September 9, 2025

AIRA Science Day 2025

On 4th September we were delighted to host the first AIRA Science Day 2025, bringing together more than 35 participants, including scientists, patients and members of the public, to share ideas and experiences ensuring the research lead by our scientists aligns with patients’ and societal needs.

Date added: Tuesday, September 9, 2025

First meeting marks launch of Europe-wide Resolution Biology network coordinated by Queen Mary University of London

On Thursday 16 October 2026, the first management committee meeting of a new Europe-wide research consortium was held in Brussels at the offices of the European Cooperation in Science and Technology (COST), marking the official start of this ambitious initiative. The meeting was hosted by COST and is coordinated by Queen Mary University of London.

Date added: Friday, October 24, 2025

Study at Queen Mary

Experience Queen Mary

Items